Table 1.
CGX (mg/kg per day) | 0 | 100 | 200 | 400 |
Mortality | - | - | - | - |
Clinical signs | NAD | NAD | NAD | NAD |
Anorexia | - | - | - | - |
Soft feces | - | - | - | - |
Food intake | NAD | NAD | NAD | NAD |
Ophthalmologic findings | NAD | NAD | NAD | NAD |
Relative organ weight | NS | NS | NS | NS |
Necropsy findings | NAD | NAD | NAD | NAD |
Histopathological findings | Rarely in some samples | Rarely in some samples | ||
Liver | Focal necrosis | Subcutaneous necrosis | ||
Lung | Yellow pigmentation | Yellow pigmentation | ||
Kidney | Glomerular hyperemia | Glomerular hyperemia | ||
Spleen | White pulp atrophy | White pulp atrophy | ||
Stomach | Helicobacter | Helicobacter |
Three male and three female beagle dogs in each group were fed CGX, and the clinical symptoms including mortality were monitored for 4 wk. At the end of the experiment, ophthalmologic, necropsy-based, and histopathological examinations were performed. NAD: No abnormality detected; NS: Not significant; -: Absent.